Lars-Olof Wahlund has a long standing high level contribution in the field of dementia and AD. The research group focuses on early diagnostics in dementia and Alzheimer´s disease. Main focus is neuroimaging and MRI. Close collaboration with preclinical and epidemiological competence locally, nationally and internationally. The group has long experience in clinical trials on anti dementia treatment. The research group was the first to publish a clinical trial on Omega 3 fatty acid and Alzheimer’s disease in October 2006. It is obvious from this that this group is a partner of this consortium.
| Contact
Prof. Lars-Olof Wahlund
Karolinska Institutet
Department of Neurobiology, Care Sciences and Society
Division of Clinical Geriatrics
Novum 5th floor
141 86 Stockholm (Sweden)
Tel: +46-8-585-8541-9
Fax: +46-8-585-8547-0
E-Mail: lars-olof.wahlund(at)ki.se
URL: http://ki.se/ki/jsp/polopoly.jsp?l=en&d=7877
|
| Contact
Dr. Miia Kivipelto
Karolinska Institutet
Division of Geriatric Epidemiology
Novum 5th floor
141 86 Stockholm (Sweden)
Tel: +46-73-994-0922
Fax: +46-8-585-8547-0
E-Mail: Miia.Kivipelto(at)ki.se
|
| Contact
Dr. Yvonne Freund-Levi, M.D.
Lic. Cognitive Psycotherapist
Karolinska Institutet
Department of Neurobiology, Care Sciences and Society
Division of Clinical Geriatrics
Novum 5th floor
Karolinska University Hospital
114 86 Stockholm (Sweden)
Tel: +46-8-585-8547-2
E-Mail: Yvonne.Freund-Levi(at)ki.se
URL: http://ki.se/ki/jsp/polopoly.jsp?a=39615&d=7877&l=sv
|
